Nam Nguyen

Mr. Nam Nguyen

University of South Florida

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2021 in Medical & Biological Engineering & Computing
Verified
Journal Article
Closed access
PDF file
HZHadi Zanddizari
Hadi Zanddizari
NNNam Nguyen
Nam Nguyen
BZBehnam Zeinali
Behnam Zeinali
JCJ. Morris Chang
J. Morris Chang

12 June 2023 in medRxiv
Verified
Preprint
Open access
PDF file
NNNam Nguyen
Nam Nguyen
JTJamie K. Teer
Jamie K. Teer
MPMargaret A. Park
Margaret A. Park
FBFrancisca Beato
Francisca Beato
PMPatricia McDonald
Patricia McDonald
AKAleksandra Karolak
Aleksandra Karolak
Motivation: Intraductal Papillary Mucinous Neoplasms (IPMNs) are a common cystic precursor for pancreatic ductal adenocarcinoma (PDAC). Detecting these pre-malignant lesions poses a challenge for diagnostic tools due to their relatively low occurrence rate. However, a better understanding of the lesions’ composition could enable effective decision-making, risk assessment, treatment selection, and, most importantly, prevention. Methods: In this work, we introduce a new framework for integrating information from mutational profiles using transformer-based models for stratification and biomarker identification in IPMNs vs. PDAC. We show that the numerical descriptor vectors can be used to construct highly predictive Artificial Neural Networks for disease classification. The derived mutational representations can be supported by other data types (here, mRNA) and further improve the accuracy of the classifiers. Besides the AI-driven methodology for biomarker discovery in cancer research, we also propose methods to maximize AI’s utility by recycling its knowledge to facilitate our limited understanding of the disease. We propose Natural Adversary Analysis – an AI-driven inference to detect IPMNs with a high probability of progression to malignancy. Results: The proposed model supports 12 clinically relevant genetic biomarkers with high mutation rates (such as KRAS, GNAS, ARID1A , and CDKN2A ) and suggests biomarkers not yet recognized (such as RADIL, TTN , and ZNF287 ). We broaden the study’s scope by investigating rarely mutated genes and reveal 14 biomarkers with potential clinical importance. Several genes with low mutation rates, including TMPRSS1, CDH22, CCND2, CYFIP2, CBLL1 , and OPCML , are also addressed as potential biomarkers by our framework. Finally, the predictive robustness of the identified biomarker set is validated externally on the patient data from the Moffitt Cancer Center study, including six pairs of matched tumor and normal IPMN samples. We show that the presented mutational profile (MP-derived) gene panel has equivalent predictive power to clinically driven panels. Conclusions: Here, we show the proof-of-concept that AI can serve the clinic and discover biomarkers beyond clinically known regimes. In line with that, we propose a translational AI-based approach for 1) disease stratification (IPMNs vs. PDAC), 2) biomarker identification, and 3) transferring the model knowledge to predict cysts’ risk of progression.

9 May 2020 in arXiv
Verified
Preprint
Open access
PDF file
DZDi Zhuang
Di Zhuang
NNNam Nguyen
Nam Nguyen
KCKeyu Chen
Keyu Chen
JCJ. Morris Chang
J. Morris Chang
As the advancement of deep learning (DL), the Internet of Things and cloud computing techniques for biomedical and healthcare problems, mobile healthcare systems have received unprecedented attention. Since DL techniques usually require enormous amount of computation, most of them cannot be directly deployed on the resource-constrained mobile and IoT devices. Hence, most of the mobile healthcare systems leverage the cloud computing infrastructure, where the data collected by the mobile and IoT devices would be transmitted to the cloud computing platforms for analysis. However, in the contested environments, relying on the cloud might not be practical at all times. For instance, the satellite communication might be denied or disrupted. We propose SAIA, a Split Artificial Intelligence Architecture for mobile healthcare systems. Unlike traditional approaches for artificial intelligence (AI) which solely exploits the computational power of the cloud server, SAIA could not only relies on the cloud computing infrastructure while the wireless communication is available, but also utilizes the lightweight AI solutions that work locally on the client side, hence, it can work even when the communication is impeded. In SAIA, we propose a meta-information based decision unit, that could tune whether a sample captured by the client should be operated by the embedded AI (i.e., keeping on the client) or the networked AI (i.e., sending to the server), under different conditions. In our experimental evaluation, extensive experiments have been conducted on two popular healthcare datasets. Our results show that SAIA consistently outperforms its baselines in terms of both effectiveness and efficiency.

29 October 2021 in arXiv
Verified
Preprint
Open access
PDF file
NNNam Nguyen
Nam Nguyen
JCJ. Morris Chang
J. Morris Chang
This paper proposes a novel cell-based neural architecture search algorithm (NAS), which completely alleviates the expensive costs of data labeling inherited from supervised learning. Our algorithm capitalizes on the effectiveness of self-supervised learning for image representations, which is an increasingly crucial topic of computer vision. First, using only a small amount of unlabeled train data under contrastive self-supervised learning allow us to search on a more extensive search space, discovering better neural architectures without surging the computational resources. Second, we entirely relieve the cost for labeled data (by contrastive loss) in the search stage without compromising architectures' final performance in the evaluation phase. Finally, we tackle the inherent discrete search space of the NAS problem by sequential model-based optimization via the tree-parzen estimator (SMBO-TPE), enabling us to reduce the computational expense response surface significantly. An extensive number of experiments empirically show that our search algorithm can achieve state-of-the-art results with better efficiency in data labeling cost, searching time, and accuracy in final validation.